Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 5, 1998, Pages 1069-1075

  Lee, W Robert ^a   Berkey, B ^b   Marcial, V ^c   Fu, K K ^d   Cooper, J S ^e   Vikram, B ^f   Coia, L R ^g   Rotman, M ^h   Ortiz, H ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b RTOG Headquarters   (United States)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NEW YORK UNIVERSITY   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

^g FOX CHASE CANCER CENTER   (United States)

^h SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Anemia; Etanidazole; Head and neck carcinoma; Hypoxic cell sensitizer

Indexed keywords

ETANIDAZOLE; HEMOGLOBIN; RADIOSENSITIZING AGENT;

ADULT; ANEMIA; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PHARYNX CARCINOMA; PRIORITY JOURNAL; RADIOSENSITIZATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANEMIA; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; ETANIDAZOLE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; SURVIVAL RATE; TREATMENT FAILURE;

EID: 0032425228     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00348-4     Document Type: Article

References (21)

1. Mottram J.C., Eidinow A. On the effect of anaemia on the reactions of the skin and of tumors to radium exposure. Br J Surg. 19:1932;481-487.
2. Bentzen S.M., Johansen L.V., Overgaard J., et al. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 20:1991;1197-1206.
3. Blitzer P.H., Wang C.C., Suit H.D. Blood pressure and hemoglobin concentration: Multivariate analysis of local control after irradiation for head and neck cancer. Int J Radiat Oncol Biol Phys. 10:(Suppl. 2):1984;98.
4. Bush R.S., Jenkin D.T., Allt W.E.C., et al. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer. 37:(Suppl. III):1978;302-302.
5. Bush R.S. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys. 12:1986;2047-2050.
6. Dische S., Anderson P.J. Carcinoma of the cervix: Anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol. 56:1983;251-255.
7. Fein D.A., Lee W.R., Hanlon A.L., et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol. 13:1995;2077-2083.
8. Greven K.M., Solin L.J., Hanks G.E. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer. 65:1990;908-912.
9. Overgaard J., Hansen H.S., Jorgensen K., et al. Primary radiotherapy of larynx and pharynx carcinoma: An analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys. 12:1986;515-521.
10. Overgaard J., Hansen H.S., Andersen A.P., et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of the larynx and pharynx: Report of the DAHANCA 2 study. Int J Radiat Oncol Biol Phys. 16:1989;1065-1068.
11. Overgaard J., Hansen H.S., Lindelov B., et al. Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. Radiother Oncol. 20:1991;143-149.
12. Quilty P.M., Duncan W. The influence of hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon irradiation. Int J Radiat Oncol Biol Phys. 12:1986;1735-1742.
13. Taskinen P.J. Radiotherapy and TNM classification of cancer of the larynx. Acta Radiol. 287:(Suppl):1969;60-62.
14. van Acht M.J.J., Hermans J., Boks D.E.S., et al. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother Oncol. 23:1992;229-235.
15. Vigario G., Kurohara S.S., George F.W. Association of hemoglobin levels before and during radiotherapy with prognosis in uterine cervix cancer. Radiology. 106:1973;649-652.
16. Lee D.-J., Cosmatos D., Marcial V.A., et al. Results of an RTOG Phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys. 32:1995;567-576.
17. Dische S., Saunders M.I., Warburton M.F. Hemoglobin, radiation, morbidity and survival 5. Bush RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys. 12:1986;1335-1337.
18. Fazekas J., Pajak T.F., Wasserman T., et al. Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck. Int J Radiat Oncol Biol Phys. 13:1987;1155-1160.
19. Fazekas J.T., Scott C., Marcial V., et al. The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: Based on RTOG trial #79-15. Int J Radiat Oncol Biol Phys. 17:1989;1177-1181.
20. Lavey R.S., Dempsey W.H. Erythrpoietin increases hemoglobin in cancer patients during radiation therapy. Int J Radiat Oncol Biol Phys. 27:1993;1147-1152.
21. Vijayakumar S., Roach M., Wara W., et al. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Preliminary results of a randomized, open-labeled, Phase II trial. Int J Radiat Oncol Biol Phys. 26:1993;721-729.